Lotus Pharmaceutical (1795.TW) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
0.16
2.19
4.22
6.25

Details

Expected EPS
6.250816655915
Actual EPS
6.024155140146
Surprise EPS
-0.23
Surprise Percent
+3.63%

Description

Lotus Pharmaceutical (1795.TW) has reported earnings of 6.024155140146 per share for Q4 2024.

0 Comments

Share your thoughts